Australia Stock Alert

AUSTR

CLOSING UPDATE: CSL increases 1.8%, led S&P/ASX 200 Health Care index higher October 18, 2017 16:00:00 AEST

NEWS BITES - AUSTRALIA

This is an end of day Alert, produced after today's Australian market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, has increased 1.8% to trade at $A141.45 vs. the S&P/ASX 200 Health Care index which strengthened 261.3 points (or 1.1%) to 23,928.8. Representing a weighting of about 48.4% of the index, the stock accounted for 79.2% of today's gain. Compared with the All Ordinaries Index which fell 3.3 points (or 0.06%) in the day, this represented a relative price increase of 1.9%.

Technical indicators complementing today's significant uptrend:

+ The positive 2.21 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ The price lifted 3.5% in the last week and jumped 7.6% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Return on Assets 14.7% [10.8%]

Other Bullish Signals include:

+ Interest cover is less leveraged at 19.8 times.

+ Total Liabilities/EBITDA of 3.3 is comfortably below the Joseph Piotroski benchmark of <5.

+ Net profit margin has averaged 21.6% in the last 3 years. This is considered superior and suggests a high margin of safety.

Note

Bearish Signals:

Tobin's Q Ratio is 5.5. Compared with the rest of the market the stock is overvalued and ranks in the bottom quartile of stocks by value of Q Ratio.

Overbought/Bearish:

The 1.8% discount to 12-month high of $A144.0 against the 56.5% premium to 12-month low of $A90.38 suggests the climb might be peaking.

TODAY'S ALERTS

Afternoon Alert: CSL lifts 2.2%, leads market higher

October 18, 2017 13:00:00 AEST

CSL Limited (ASX:CSL) has lifted 2.2% to trade at $A142.04 vs. the All Ordinaries Index which strengthened 9.7 points (or 0.2%) to 5,967.8. Representing a weighting of about 3.3% of the index, the stock accounted for 45.6% of today's gain.

Morning Alert: CSL increases 0.4%, leads S&P/ASX 200 Health Care index higher

October 18, 2017 11:00:00 AEST

CSL Limited (ASX:CSL) has increased 0.4% to trade at $A139.56 vs. the S&P/ASX 200 Health Care index which strengthened 97.2 points (or 0.4%) to 23,764.7. Representing a weighting of about 48.1% of the index, the stock accounted for 51.7% of today's gain.

RECENT ALERTS

CLOSING UPDATE: CSL increases further 0.1%, led S&P/ASX 200 Health Care index higher

October 17, 2017 16:00:00 AEST

CSL, Australia's largest pharmaceuticals & biotechnology company by market capitalisation, has increased 0.6% to trade at $A138.95 vs. the S&P/ASX 200 Health Care index which strengthened 102.2 points (or 0.4%) to 23,667.5. Representing a weighting of about 48.1% of the index, the stock accounted for 69.3% of today's gain. Trading volume was 60% of average at the end of the day. Compared with the All Ordinaries Index which rose 40.9 points (or 0.7%) in the day, this represented a relative price change of -0.1%.

Afternoon Alert: CSL increases 0.5%, leads S&P/ASX 200 Health Care index higher

October 17, 2017 13:00:00 AEST

CSL Limited (ASX:CSL) has increased 0.5% to trade at $A138.84 vs. the S&P/ASX 200 Health Care index which strengthened 115.3 points (or 0.5%) to 23,680.6. Representing a weighting of about 48.0% of the index, the stock accounted for 52.9% of today's gain.

CSL Limited (AU:CSL; ASX:CSL; AX:CSL)

ISIN: AU000000CSL8

PermID: 4295856855

Source: www.BuySellSignals.com